Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Change in Acquisitions & Divestments (2016 - 2021)

Immucell (ICCC) has disclosed Change in Acquisitions & Divestments for 11 consecutive years, with -$996000.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Change in Acquisitions & Divestments rose 49.31% year-over-year to -$996000.0, compared with a TTM value of -$996000.0 through Dec 2021, up 71.12%, and an annual FY2021 reading of -$996000.0, up 71.12% over the prior year.
  • Change in Acquisitions & Divestments was -$996000.0 for Q1 2021 at Immucell, roughly flat from -$996000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $2.7 million in Q1 2017 and bottomed at -$11.6 million in Q3 2019.
  • Average Change in Acquisitions & Divestments over 4 years is -$1.5 million, with a median of -$996000.0 recorded in 2020.
  • Peak annual rise in Change in Acquisitions & Divestments hit 450.6% in 2017, while the deepest fall reached 75.45% in 2017.
  • Year by year, Change in Acquisitions & Divestments stood at $487000.0 in 2017, then plummeted by 1063.86% to -$4.7 million in 2019, then surged by 78.78% to -$996000.0 in 2020, then changed by 0.0% to -$996000.0 in 2021.
  • Business Quant data shows Change in Acquisitions & Divestments for ICCC at -$996000.0 in Q1 2021, -$996000.0 in Q4 2020, and -$2.0 million in Q3 2020.